Evaluation of circadian phenotypes utilizing fibroblasts from patients with circadian rhythm sleep disorders

A. Hida, Y. Ohsawa, S. Kitamura, K. Nakazaki, N. Ayabe, Y. Motomura, K. Matsui, M. Kobayashi, A. Usui, Y. Inoue, H. Kusanagi, Y. Kamei, K. Mishima

研究成果: ジャーナルへの寄稿学術誌査読

17 被引用数 (Scopus)

抄録

We evaluated the circadian phenotypes of patients with delayed sleep-wake phase disorder (DSWPD) and non-24-hour sleep-wake rhythm disorder (N24SWD), two different circadian rhythm sleep disorders (CRSDs) by measuring clock gene expression rhythms in fibroblast cells derived from individual patients. Bmal1-luciferase (Bmal1-luc) expression rhythms were measured in the primary fibroblast cells derived from skin biopsy samples of patients with DSWPD and N24SWD, as well as control subjects. The period length of the Bmal1-luc rhythm (in vitro period) was distributed normally and was 22.80 ± 0.47 (mean ± s.d.) h in control-derived fibroblasts. The in vitro periods in DSWPD-derived fibroblasts and N24SWD-derived fibroblasts were 22.67 ± 0.67 h and 23.18 ± 0.70 h, respectively. The N24SWD group showed a significantly longer in vitro period than did the control or DSWPD group. Furthermore, in vitro period was associated with response to chronotherapy in the N24SWD group. Longer in vitro periods were observed in the non-responders (mean ± s.d.: 23.59 ± 0.89 h) compared with the responders (mean ± s.d.: 22.97 ± 0.47 h) in the N24SWD group. Our results indicate that prolonged circadian periods contribute to the onset and poor treatment outcome of N24SWD. In vitro rhythm assays could be useful for predicting circadian phenotypes and clinical prognosis in patients with CRSDs.

本文言語英語
論文番号e1106
ジャーナルTranslational psychiatry
7
4
DOI
出版ステータス出版済み - 2017
外部発表はい

!!!All Science Journal Classification (ASJC) codes

  • 精神医学および精神衛生
  • 細胞および分子神経科学
  • 生物学的精神医学

フィンガープリント

「Evaluation of circadian phenotypes utilizing fibroblasts from patients with circadian rhythm sleep disorders」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル